Cargando…
Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag KG
2020
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738232/ https://www.ncbi.nlm.nih.gov/pubmed/33336140 http://dx.doi.org/10.1055/s-0040-1721501 |
| _version_ | 1783623088008593408 |
|---|---|
| author | Frise, Matthew C. Gates, Rebecca E.V. Curry, Nicola S. Danbury, Christopher M. |
| author_facet | Frise, Matthew C. Gates, Rebecca E.V. Curry, Nicola S. Danbury, Christopher M. |
| author_sort | Frise, Matthew C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7738232 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Georg Thieme Verlag KG |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77382322020-12-16 Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19 Frise, Matthew C. Gates, Rebecca E.V. Curry, Nicola S. Danbury, Christopher M. TH Open Georg Thieme Verlag KG 2020-12-15 /pmc/articles/PMC7738232/ /pubmed/33336140 http://dx.doi.org/10.1055/s-0040-1721501 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Frise, Matthew C. Gates, Rebecca E.V. Curry, Nicola S. Danbury, Christopher M. Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19 |
| title | Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19 |
| title_full | Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19 |
| title_fullStr | Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19 |
| title_full_unstemmed | Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19 |
| title_short | Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19 |
| title_sort | successful use of argatroban to treat a critically ill patient with coagulopathy and nephropathy secondary to covid-19 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738232/ https://www.ncbi.nlm.nih.gov/pubmed/33336140 http://dx.doi.org/10.1055/s-0040-1721501 |
| work_keys_str_mv | AT frisematthewc successfuluseofargatrobantotreatacriticallyillpatientwithcoagulopathyandnephropathysecondarytocovid19 AT gatesrebeccaev successfuluseofargatrobantotreatacriticallyillpatientwithcoagulopathyandnephropathysecondarytocovid19 AT currynicolas successfuluseofargatrobantotreatacriticallyillpatientwithcoagulopathyandnephropathysecondarytocovid19 AT danburychristopherm successfuluseofargatrobantotreatacriticallyillpatientwithcoagulopathyandnephropathysecondarytocovid19 |